{"id":"https://openalex.org/W2783179629","doi":"https://doi.org/10.1136/annrheumdis-2017-211568","title":"Early and sustained efficacy with apremilast monotherapy in biological-na\u00efve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)","display_name":"Early and sustained efficacy with apremilast monotherapy in biological-na\u00efve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)","alternate_titles":[],"publication_year":2018,"publication_date":"2018-04-12","ids":{"openalex":"https://openalex.org/W2783179629","doi":"https://doi.org/10.1136/annrheumdis-2017-211568","mag":"2783179629","pmid":"https://pubmed.ncbi.nlm.nih.gov/29343507","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5909747"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2017-211568","doi":"https://doi.org/10.1136/annrheumdis-2017-211568","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2017-211568","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/5/690.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2783179629"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ard.bmj.com/content/annrheumdis/77/5/690.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011826741","display_name":"Peter T. Nash","orcid":"https://orcid.org/0000-0002-2571-788X","observed_orcids":["https://orcid.org/0000-0002-2571-788X"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Peter Nash","raw_affiliation_strings":["Department of Medicine, University of Queensland, Brisbane, Queensland, Australia","Department of Medicine","University of Queensland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Queensland, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"University of Queensland","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046834305","display_name":"Kamal Ohson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130438778","display_name":"Memorial University of Newfoundland","ror":"https://ror.org/04haebc03","country_code":"CA","type":"education","lineage":["https://openalex.org/I130438778"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kamal Ohson","raw_affiliation_strings":["Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada","Memorial University of Newfoundland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada","institution_ids":["https://openalex.org/I130438778"]},{"raw_affiliation_string":"Memorial University of Newfoundland","institution_ids":["https://openalex.org/I130438778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033565189","display_name":"Jessica A. Walsh","orcid":"https://orcid.org/0000-0002-4563-0845","observed_orcids":["https://orcid.org/0000-0002-4563-0845"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Walsh","raw_affiliation_strings":["Department of Internal Medicine, Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, Utah, USA","Department of Internal Medicine, Division of Rheumatology","University of Utah School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, Utah, USA","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Department of Internal Medicine, Division of Rheumatology","institution_ids":[]},{"raw_affiliation_string":"University of Utah School of Medicine","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034905722","display_name":"Nikolay G. Delev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikolay Delev","raw_affiliation_strings":["Celgene Corporation, Summit, New Jersey, USA","Celgene Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, New Jersey, USA","institution_ids":["https://openalex.org/I4387155837"]},{"raw_affiliation_string":"Celgene Corporation","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109559920","display_name":"Dianne D. Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dianne Nguyen","raw_affiliation_strings":["Celgene Corporation, Summit, New Jersey, USA","Celgene Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, New Jersey, USA","institution_ids":["https://openalex.org/I4387155837"]},{"raw_affiliation_string":"Celgene Corporation","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112357571","display_name":"Lichen L. Teng","orcid":"https://orcid.org/0000-0002-5840-0723","observed_orcids":["https://orcid.org/0000-0002-5840-0723"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lichen Teng","raw_affiliation_strings":["Celgene Corporation, Summit, New Jersey, USA","Celgene Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, New Jersey, USA","institution_ids":["https://openalex.org/I4387155837"]},{"raw_affiliation_string":"Celgene Corporation","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071926023","display_name":"Juan Jes\u00fas G\u00f3mez-Reino","orcid":"https://orcid.org/0000-0001-5229-6294","observed_orcids":["https://orcid.org/0000-0001-5229-6294"]},"institutions":[{"id":"https://openalex.org/I4210096311","display_name":"Complejo Hospitalario Universitario de Santiago","ror":"https://ror.org/00mpdg388","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096311"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan J G\u00f3mez-Reino","raw_affiliation_strings":["Hospital Cl\u00ednico Universitario, Santiago, Spain","Hospital Cl\u00ednico Universitario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Cl\u00ednico Universitario, Santiago, Spain","institution_ids":["https://openalex.org/I4210096311"]},{"raw_affiliation_string":"Hospital Cl\u00ednico Universitario","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021376488","display_name":"Jacob A. Aelion","orcid":"https://orcid.org/0000-0001-5727-7199","observed_orcids":["https://orcid.org/0000-0001-5727-7199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob A Aelion","raw_affiliation_strings":["West Tennessee Research Institute, Jackson, Tennessee, USA","West Tennessee Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Tennessee Research Institute, Jackson, Tennessee, USA","institution_ids":[]},{"raw_affiliation_string":"West Tennessee Research Institute","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5011826741"],"corresponding_institution_ids":["https://openalex.org/I165143802"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":{"value":4870,"currency":"USD","value_usd":4870},"fwci":9.4605,"has_fulltext":true,"cited_by_count":96,"citation_normalized_percentile":{"value":0.98838094,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"77","issue":"5","first_page":"690","last_page":"698"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apremilast","display_name":"apremilast","score":0.9620000123977661},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/early-treatment-response","display_name":"early treatment response","score":0.7429999709129333},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.6230000257492065},{"id":"https://openalex.org/keywords/enthesitis","display_name":"enthesitis","score":0.9120000004768372},{"id":"https://openalex.org/keywords/health-assessment-questionnaire-disability-index","display_name":"HAQ-DI","score":0.7120000123977661},{"id":"https://openalex.org/keywords/das28","display_name":"DAS28","score":0.8019999861717224},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.5849999785423279},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.753000020980835},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.5609999895095825},{"id":"https://openalex.org/keywords/active-trial","display_name":"ACTIVE trial","score":0.4779999852180481},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.4659999907016754},{"id":"https://openalex.org/keywords/ppardelta-agonist","display_name":"PPAR\u03b4 agonist","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9738794565200806},{"id":"https://openalex.org/C2781427535","wikidata":"https://www.wikidata.org/wiki/Q2858961","display_name":"Apremilast","level":4,"score":0.9302671551704407},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.829710841178894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4682190418243408},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.41777801513671875},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41429150104522705},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4087171256542206}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D004185","descriptor_name":"Disability Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1136/annrheumdis-2017-211568","doi":"https://doi.org/10.1136/annrheumdis-2017-211568","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2017-211568","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/5/690.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4837699","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5909747","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:29343507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29343507","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:5909747","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5909747/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Rheum Dis","raw_type":"Text"},{"id":"pmh:oai:dnet:ruc_________::f51d8ea42c656f18e96a36144f7f0677","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2183/25186","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:77/5/690","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/77/5/690","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:research-repository.griffith.edu.au:10072/399807","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10072/399807","pdf_url":null,"source":{"id":"https://openalex.org/S7407064376","display_name":"Griffith Research Online","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"},{"id":"pmh:oai:ruc.udc.es:2183/25186","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2183/25186","pdf_url":null,"source":{"id":"https://openalex.org/S4306402204","display_name":"RUC (Universidade Da Coru\u00f1a)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I11019714","host_organization_name":"Universidade da Coru\u00f1a","host_organization_lineage":["https://openalex.org/I11019714"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2017-211568","doi":"https://doi.org/10.1136/annrheumdis-2017-211568","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2017-211568","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/5/690.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2783179629.pdf","grobid_xml":"https://content.openalex.org/works/W2783179629.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1521666696","https://openalex.org/W1919283206","https://openalex.org/W1982303764","https://openalex.org/W1991656070","https://openalex.org/W2022466169","https://openalex.org/W2023333262","https://openalex.org/W2054242247","https://openalex.org/W2058968313","https://openalex.org/W2082308494","https://openalex.org/W2083180635","https://openalex.org/W2131082989","https://openalex.org/W2131727392","https://openalex.org/W2147064041","https://openalex.org/W2166077573","https://openalex.org/W2223868808","https://openalex.org/W2266045195","https://openalex.org/W2471133371","https://openalex.org/W2550121548","https://openalex.org/W2754682129"],"related_works":["https://openalex.org/W2755260379","https://openalex.org/W2808313322","https://openalex.org/W2131082989","https://openalex.org/W4322718679","https://openalex.org/W2795686103","https://openalex.org/W2471133371","https://openalex.org/W3169159864","https://openalex.org/W4385694242","https://openalex.org/W1981700374","https://openalex.org/W2266045195"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Evaluate":[1],"apremilast":[2,25,58,88,144,151,232],"efficacy":[3,114],"across":[4],"various":[5],"psoriatic":[6],"arthritis":[7],"(PsA)":[8],"manifestations":[9],"beginning":[10],"at":[11,80,99,145,235],"week":[12,33,53,60,81,100,146,149,179,236,241],"2":[13,101,237],"in":[14,112,161,194],"biological-na\u00efve":[15,224],"patients":[16,35,56,66,225],"with":[17,87,143,159,175,189,226,231,248],"PsA.":[18,197],"METHODS:":[19],"Patients":[20],"were":[21,47,104,141,173,216],"randomised":[22,65],"(1:1)":[23],"to":[24],"30":[26],"mg":[27],"twice":[28],"daily":[29],"or":[30],"placebo.":[31],"At":[32,52,148],"16,":[34,150],"whose":[36],"swollen":[37,128],"and":[38,137,167,196,209,219,238],"tender":[39],"joint":[40,129],"counts":[41],"had":[42],"not":[43],"improved":[44],"by":[45],"\u226510%":[46],"eligible":[48],"for":[49],"early":[50],"escape.":[51],"24,":[54],"all":[55],"received":[57],"through":[59,178,240],"52.":[61,180,242],"RESULTS:":[62],"Among":[63],"219":[64],"(apremilast:":[67],"n=110;":[68],"placebo:":[69],"n=109),":[70],"a":[71],"significantly":[72,152],"greater":[73],"American":[74],"College":[75],"of":[76,203,229],"Rheumatology":[77],"20":[78],"response":[79,97],"16":[82],"(primary":[83],"outcome)":[84],"was":[85,187,206,233,246],"observed":[86,142,234],"versus":[89,107,157],"placebo":[90],"(38.2%":[91],"(42/110)":[92],"vs":[93],"20.2%":[94],"(22/109);":[95],"P=0.004);":[96],"rates":[98,215],"(first":[102],"assessment)":[103],"16.4%":[105],"(18/110)":[106],"6.4%":[108],"(7/109)":[109],"(P=0.025).":[110],"Improvements":[111,172],"other":[113],"outcomes,":[115],"including":[116],"28-joint":[117],"count":[118],"Disease":[119],"Activity":[120],"Score":[121],"(DAS-28)":[122],"using":[123],"C":[124],"reactive":[125],"protein":[126],"(CRP),":[127],"count,":[130],"Health":[131],"Assessment":[132],"Questionnaire-Disability":[133],"Index":[134,170],"(HAQ-DI),":[135],"enthesitis":[136],"morning":[138],"stiffness":[139],"severity,":[140],"2.":[147],"reduced":[153],"PsA":[154],"disease":[155],"activity":[156],"placebo,":[158],"changes":[160],"DAS-28":[162],"(CRP)":[163],"(P<0.0001),":[164],"HAQ-DI":[165],"(P=0.023)":[166],"Gladman":[168],"Enthesitis":[169],"(P=0.001).":[171],"maintained":[174],"continued":[176,239],"treatment":[177],"Over":[181],"52":[182],"weeks,":[183],"apremilast's":[184],"safety":[185,244],"profile":[186,245],"consistent":[188,247],"prior":[190],"phase":[191],"3":[192],"studies":[193],"psoriasis":[195],"During":[198],"weeks":[199],"0-24,":[200],"the":[201],"incidence":[202],"protocol-defined":[204],"diarrhoea":[205],"11.0%":[207],"(apremilast)":[208,218],"8.3%":[210],"(placebo);":[211],"serious":[212],"adverse":[213],"event":[214],"2.8%":[217],"4.6%":[220],"(placebo).":[221],"CONCLUSIONS:":[222],"In":[223],"PsA,":[227],"onset":[228],"effect":[230],"The":[243],"previous":[249],"reports.":[250],"TRIAL":[251],"REGISTRATION":[252],"NUMBER:":[253],"NCT01925768;":[254],"Results.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2783179629","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-01-26T00:00:00"}
